BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+6.88%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.54B
AUM Growth
+$9.54B
Cap. Flow
-$256M
Cap. Flow %
-2.69%
Top 10 Hldgs %
82.65%
Holding
144
New
10
Increased
13
Reduced
15
Closed
7

Top Buys

1
NTLA icon
Intellia Therapeutics
NTLA
$22.7M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$9.83M
3
MRUS icon
Merus
MRUS
$8.97M
4
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$6.59M
5
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$5.43M

Top Sells

1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
$274M
2
OMER icon
Omeros
OMER
$11.5M
3
GBT
Global Blood Therapeutics, Inc.
GBT
$9.52M
4
ATYR
aTyr Pharma
ATYR
$8.42M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.46M

Sector Composition

1 Healthcare 80.72%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INCY icon
1
Incyte
INCY
$16.5B
$1.88B 19.7% 23,498,697 +237 +0% +$19K
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
$1.75B 18.32% 43,238,967 +3,700 +0% +$150K
ABBV icon
3
AbbVie
ABBV
$372B
$890M 9.33% 14,373,538 – –
ACAD icon
4
Acadia Pharmaceuticals
ACAD
$4.38B
$796M 8.34% 24,516,738 +302,900 +1% +$9.83M
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$764M 8.01% 6,543,295 +696 +0% +$81.3K
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.2B
$374M 3.92% 4,806,483 – –
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
$354M 3.71% 13,668,866 +9,034 +0.1% +$234K
DBVT
8
DBV Technologies
DBVT
$264M
$180M 1.88% 5,509,560 – –
ACOR
9
DELISTED
Acorda Therapeutics, Inc.
ACOR
$93.4M 0.98% 3,661,082 – –
CERS icon
10
Cerus
CERS
$251M
$84.6M 0.89% 13,553,275 – –
ONCE
11
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$67.4M 0.71% 1,318,341 +55,959 +4% +$2.86M
BLCM
12
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$63.1M 0.66% 4,865,647 – –
ONC
13
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$57M 0.6% 1,912,680 – –
HRTX icon
14
Heron Therapeutics
HRTX
$207M
$51.6M 0.54% 2,857,250 -50,534 -2% -$912K
NGNE icon
15
Neurogene
NGNE
$264M
$51.3M 0.54% 7,752,487 – –
NVTA
16
DELISTED
Invitae Corporation
NVTA
$48.4M 0.51% 6,554,967 – –
BCRX icon
17
BioCryst Pharmaceuticals
BCRX
$1.74B
$42.6M 0.45% 15,010,534 – –
NBIX icon
18
Neurocrine Biosciences
NBIX
$13.8B
$40.7M 0.43% 895,422 – –
ARAV
19
DELISTED
Aravive, Inc. Common Stock
ARAV
$30.1M 0.32% 2,723,399 -476,160 -15% -$5.27M
AAAP
20
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$25.2M 0.26% 833,089 +218,056 +35% +$6.59M
XNPT
21
DELISTED
XENOPORT, INC.
XNPT
$24.5M 0.26% 3,475,672 – –
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$23.6M 0.25% 609,166 – –
SGMO icon
23
Sangamo Therapeutics
SGMO
$157M
$23.5M 0.25% 4,055,876 – –
NTLA icon
24
Intellia Therapeutics
NTLA
$1.22B
$22.7M 0.24% +1,062,120 New +$22.7M
EXEL icon
25
Exelixis
EXEL
$10.1B
$20.2M 0.21% 2,580,000 – –
1
2 3 4 5